What Are the Symptoms of Taking Ozempic? A Guide to Side Effects

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide-based medications, including the branded Ozempic and compounded alternatives, trigger specific physiological responses in your digestive system and brain. The most commonly reported side effects occur during the first weeks of treatment and typically improve as your body adjusts. PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, allowing patients to access this medication pathway with guided side-effect management.

Common Semaglutide Side Effects and Timeline

The most frequent side effects from semaglutide affect the gastrointestinal tract because the medication activates GLP-1 receptors in your stomach and intestines. Nausea is reported by 25-40% of users in clinical trials, typically peaking in the first two weeks and subsiding within 4-8 weeks. Vomiting, constipation, and diarrhea occur in smaller percentages but follow a similar pattern: onset early, resolution gradual.

Individual timing varies widely depending on starting dose, escalation speed, and genetic sensitivity factors. Some patients experience mild nausea for just a few days, while others describe a 2-3 week adjustment window. Keeping a detailed symptom log during your first month helps identify your unique response pattern and allows your prescribing provider to adjust your protocol accordingly.

Gastrointestinal Side Effects: What Happens in Your Digestive System

Semaglutide slows gastric emptying—the rate at which food leaves your stomach—which explains why nausea and fullness are so common. This same mechanism reduces appetite signaling in your brain, which is therapeutic for weight loss but can cause temporary digestive discomfort. Additionally, the medication increases secretion of glucagon-like peptide-1, which directly affects gut motility and fluid absorption in your intestines.

Constipation often emerges as nausea improves, typically appearing in weeks 2-4 of treatment. Increasing water intake to at least 80-100 ounces daily and adding dietary fiber gradually—without overwhelming your slower-moving digestive system—addresses this side effect effectively. Some patients benefit from light walking after meals or adjusting meal timing to smaller, more frequent portions. If constipation persists beyond two weeks, inform your provider, as they may recommend a stool softener or adjust your dosing schedule.

Non-Gastrointestinal Side Effects and Safety Considerations

Beyond digestive symptoms, semaglutide can cause fatigue, headaches, dizziness, and changes in appetite perception that feel unrelated to stomach function. These neurological effects stem from GLP-1 receptor activation in your brain's appetite centers and blood-sugar regulation regions. Fatigue typically emerges during rapid dose escalation and resolves within 1-2 weeks once your body acclimates to the medication's presence.

Rare but serious side effects include pancreatitis (inflammation of the pancreas), gallbladder issues, and thyroid concerns in susceptible individuals. These warrant immediate medical attention if you experience severe upper abdominal pain, persistent vomiting, or rapid heartbeat. Patients with a personal or family history of medullary thyroid cancer should not use semaglutide. PlexusDx compounded semaglutide is supplied by licensed 503A compounding pharmacies and requires a healthcare provider's prescription, ensuring medical oversight of your complete health picture.

Managing Semaglutide Side Effects: Practical Strategies

Slower dose escalation—starting with microdoses and increasing at intervals set by your prescriber, commonly about every 4 weeks rather than weekly—reduces nausea intensity for many patients. Eating smaller meals (4-6 ounces) more frequently, avoiding high-fat and spicy foods during early weeks, and staying upright for 30 minutes after eating all minimize digestive distress. Ginger supplements, peppermint tea, and anti-nausea medication prescribed by your provider offer additional relief without interfering with semaglutide's mechanism.

Hydration cannot be overstated: dehydration amplifies nausea and constipation while reducing the medication's effectiveness for blood-sugar control. Tracking your symptoms daily—including timing, severity, and any triggers you notice—gives your provider concrete data for personalizing your dosing schedule. PlexusDx's approach emphasizes patient support during this adjustment phase, recognizing that most side effects resolve within 4-8 weeks if managed proactively. The Precision Peptide Genetic Test (available for $298) identifies your individual genetic predispositions along the GLP-1 pathway, helping optimize your medication selection and dosing strategy for faster tolerance development.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How long do Ozempic and compounded semaglutide side effects typically last?

Most side effects peak during the first 2-3 weeks of treatment and resolve within 4-8 weeks as your body adapts. Nausea is the earliest symptom to appear and often the first to disappear, while constipation may emerge later but also improves with dietary adjustments. Individual timelines vary; some patients adjust in days while others require several weeks.

Can I prevent nausea when starting semaglutide?

Yes. Using a slower dose escalation (especially microdose protocols like PlexusDx's $129/month Microdose GLP-1 Protocol), eating smaller frequent meals, avoiding high-fat foods, and staying well-hydrated all reduce nausea severity significantly. Starting low and advancing gradually gives your GLP-1 receptors time to stabilize, minimizing the shock to your gastrointestinal system.

Is compounded semaglutide from PlexusDx as safe as brand-name Ozempic?

PlexusDx's compounded semaglutide comes from licensed 503A compounding pharmacies, which are regulated by state boards of pharmacy and USP compounding standards rather than the FDA approval and CGMP requirements that apply to commercial manufacturers. While compounded medications are not FDA-approved as branded products, the active pharmaceutical ingredient is identical. Both require a healthcare provider's prescription and carry the same potential side effects and safety profile.

What side effects should prompt me to stop taking semaglutide immediately?

Seek immediate medical attention for severe upper abdominal pain (possible pancreatitis), persistent vomiting preventing food or fluid intake, rapid or irregular heartbeat, vision changes, or signs of thyroid problems. Most common side effects are uncomfortable but not dangerous; these rare serious effects require emergency evaluation.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test examines genetic variants affecting GLP-1 receptor function, appetite regulation, and metabolic pathways. Individuals with certain variants at GLP1R rs6923761 or MC4R rs17782313 may experience side effects differently, allowing your provider to personalize dosing and select between semaglutide or tirzepatide for your best tolerance. The test is $298.

Related Reading

• Ozempic Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.